Evidence map›Paper›PMID 40388884›Full record

ArticleJournal of neurosurgery. Case lessons2025

Calcifying pseudoneoplasm of the neuraxis progressing to G5/PDGFRA subgroup glioblastoma in a United States Army veteran with a history of head trauma and germline POT1 and EPHB2 mutations: illustrative case.

Maria-Magdalena Georgescu, Adriana Olar, William Daniel Zollinger

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria-Magdalena GeorgescuNeuroMarkers, Houston, Texas.
Adriana OlarNOMIX Laboratories, Denver, Colorado.
William Daniel ZollingerNortheast Louisiana Radiation Oncology, Monroe, Louisiana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTrauma-associated glioblastoma has been previously described, albeit without molecular characterization. OBSERVATIONS: The authors show the integrated clinical/pathologic/molecular analysis of a glioblastoma developing 43 years after head trauma sustained by a United States veteran. An epileptogenic benign lesion developed at the trauma site, followed 34 years later by a calcified lesion diagnosed as calcifying pseudoneoplasm of the neuraxis (CAPNON) that recurred 9 years later as glioblastoma with heterotopic/metaplastic ossification. Genomic analysis showed novel germline mutations in the telomere maintenance factor POT1 p.W184* and receptor tyrosine kinase (RTK) EPHB2 p.W792*. The somatic alterations included second-hit POT1 p.D163Y mutation, CDKN2A/2B homozygous loss, DNMT3A mutation and PDGFRA amplification, classifying this glioblastoma in the G5/PDGFRA molecular subgroup. Proliferation markers, PDGFRA, MAPK feedback inhibitors, and EPHB1 showed high expression, whereas EPHB3 and EPHA7 showed the highest expression of all glioblastomas. Following gross-total resection, the patient received adjuvant radiotherapy and temozolomide and died 16.3 months later. LESSONS: This is the first report of CAPNON progression to glioblastoma and of molecularly characterized glioma occurring decades after head trauma. A multifactorial etiology including genetic predisposition and posttraumatic repair is hypothesized. The discussion presents possible roles of EPH RTKs in posttraumatic repair and CAPNON, and of POT1 and PDGFRα in subsequent progression to glioblastoma. https://thejns.org/doi/10.3171/CASE25152.

Indexed as

CAPNONcase reportEPHB2EPHB7 receptor tyrosine kinasesgermline mutationsheterotopicmetaplastic ossificationPDGFRAposttraumatic glioblastomaPOT1trauma

Identifiers

PMID40388884
PMCPMC12087366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.